1hty: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1hty" size="450" color="white" frame="true" align="right" spinBox="true" caption="1hty, resolution 1.40Å" /> '''GOLGI ALPHA-MANNOSID...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1hty.gif|left|200px]]<br /><applet load="1hty" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1hty.gif|left|200px]]<br /><applet load="1hty" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1hty, resolution 1.40&Aring;" />
caption="1hty, resolution 1.40&Aring;" />
'''GOLGI ALPHA-MANNOSIDASE II'''<br />
'''GOLGI ALPHA-MANNOSIDASE II'''<br />


==Overview==
==Overview==
Golgi alpha-mannosidase II, a key enzyme in N-glycan processing, is a, target in the development of anti- cancer therapies. The crystal structure, of Drosophila Golgi alpha-mannosidase II in the absence and presence of, the anti-cancer agent swainsonine and the inhibitor deoxymannojirimycin, reveals a novel protein fold with an active site zinc intricately involved, both in the substrate specificity of the enzyme and directly in the, catalytic mechanism. Identification of a putative GlcNAc binding pocket in, the vicinity of the active site cavity provides a model for the binding of, the GlcNAcMan(5)GlcNAc(2) substrate and the consecutive hydrolysis of the, alpha1,6- and alpha1,3-linked mannose residues. The enzyme-inhibitor, interactions observed provide insight into the catalytic mechanism, opening the door to the design of novel inhibitors of alpha-mannosidase, II.
Golgi alpha-mannosidase II, a key enzyme in N-glycan processing, is a target in the development of anti- cancer therapies. The crystal structure of Drosophila Golgi alpha-mannosidase II in the absence and presence of the anti-cancer agent swainsonine and the inhibitor deoxymannojirimycin reveals a novel protein fold with an active site zinc intricately involved both in the substrate specificity of the enzyme and directly in the catalytic mechanism. Identification of a putative GlcNAc binding pocket in the vicinity of the active site cavity provides a model for the binding of the GlcNAcMan(5)GlcNAc(2) substrate and the consecutive hydrolysis of the alpha1,6- and alpha1,3-linked mannose residues. The enzyme-inhibitor interactions observed provide insight into the catalytic mechanism, opening the door to the design of novel inhibitors of alpha-mannosidase II.


==About this Structure==
==About this Structure==
1HTY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Drosophila_melanogaster Drosophila melanogaster] with NAG, ZN, TRS and MRD as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Mannosyl-oligosaccharide_1,3-1,6-alpha-mannosidase Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.114 3.2.1.114] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1HTY OCA].  
1HTY is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Drosophila_melanogaster Drosophila melanogaster] with <scene name='pdbligand=NAG:'>NAG</scene>, <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=TRS:'>TRS</scene> and <scene name='pdbligand=MRD:'>MRD</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Mannosyl-oligosaccharide_1,3-1,6-alpha-mannosidase Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.2.1.114 3.2.1.114] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HTY OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase]]
[[Category: Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase]]
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Elsen, J.M.H.van.den.]]
[[Category: Elsen, J M.H van den.]]
[[Category: Kuntz, D.A.]]
[[Category: Kuntz, D A.]]
[[Category: Rose, D.R.]]
[[Category: Rose, D R.]]
[[Category: MRD]]
[[Category: MRD]]
[[Category: NAG]]
[[Category: NAG]]
Line 25: Line 25:
[[Category: three helix bundle]]
[[Category: three helix bundle]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Nov 20 16:49:39 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 13:04:47 2008''

Revision as of 11:04, 21 February 2008

File:1hty.gif


1hty, resolution 1.40Å

Drag the structure with the mouse to rotate

GOLGI ALPHA-MANNOSIDASE II

Overview

Golgi alpha-mannosidase II, a key enzyme in N-glycan processing, is a target in the development of anti- cancer therapies. The crystal structure of Drosophila Golgi alpha-mannosidase II in the absence and presence of the anti-cancer agent swainsonine and the inhibitor deoxymannojirimycin reveals a novel protein fold with an active site zinc intricately involved both in the substrate specificity of the enzyme and directly in the catalytic mechanism. Identification of a putative GlcNAc binding pocket in the vicinity of the active site cavity provides a model for the binding of the GlcNAcMan(5)GlcNAc(2) substrate and the consecutive hydrolysis of the alpha1,6- and alpha1,3-linked mannose residues. The enzyme-inhibitor interactions observed provide insight into the catalytic mechanism, opening the door to the design of novel inhibitors of alpha-mannosidase II.

About this Structure

1HTY is a Single protein structure of sequence from Drosophila melanogaster with NAG, ZN, TRS and MRD as ligands. Active as Mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase, with EC number 3.2.1.114 Full crystallographic information is available from OCA.

Reference

Structure of Golgi alpha-mannosidase II: a target for inhibition of growth and metastasis of cancer cells., van den Elsen JM, Kuntz DA, Rose DR, EMBO J. 2001 Jun 15;20(12):3008-17. PMID:11406577

Page seeded by OCA on Thu Feb 21 13:04:47 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA